How Recent Pharma Tariff Delays Could Impact J&J’s Share Price in 2025

If you are standing at a crossroads with Johnson & Johnson's stock, you are not alone. The past several months have given investors plenty to think about, especially as J&J continues to find its footing amid policy headlines and global market shifts. The stock recently closed at $179.29, reflecting a 12.5% gain over the past year and a steady climb of 33.8% in five years. Those are numbers that catch attention, but the real question is what they say about the future value for new and existing...